Inside SMP proteomics: six years German Human Brain Proteome Project (HBPP) - a summary.
In 2001, the German Federal Ministry of Education and Research (BMBF) initiated the National Genome Research Network (NGFN; www.ngfn.de) as a nation-wide multidisciplinary networking platform aiming at the analysis of common human diseases and aging. Within the NGFN the Human Brain Proteome Project (HBPP; www.smp-proteomics.de) focuses on the analysis of the human brain in health and disease. The concept is based on two consecutive steps: (i) Elaborating and establishing the necessary technology platforms. (ii) Application of the established technologies for research in Alzheimer's disease and Parkinson's disease. In the first funding period, HBPP1, running from 2001 to 2004, necessary technologies were established and optimized. In HBPP2, which started 2004 and will end in May 2008, the developed technologies are used for large-scale experiments, offering new links for disease related research and therapies. The following overview describes structure, aims and outcome of this unique German Brain Proteome Project.
Hamacher
Michael
M
Medizinisches Proteom-Center, Ruhr-Universität Bochum, Bochum, Germany. Michael.Hamacher@rub.de
Hardt
Tanja
T
van Hall
Andre
A
Stephan
Christian
C
Marcus
Katrin
K
Meyer
Helmut E
HE
D000544:Alzheimer Disease / Q000378:metabolism / Q000473:pathology; D035843:Biomedical Research / Q000458:organization & administration / Q000639:trends; D001921:Brain / Q000378:metabolism* / Q000473:pathology; D005858:Germany; D006801:Humans; D010300:Parkinson Disease / Q000378:metabolism / Q000473:pathology; D020543:Proteome / Q000032:analysis*; D040901:Proteomics / Q000379:methods* / Q000639:trends
D020543:Proteome